mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.01 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
-0.15 |
0.01 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.01 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
0.15 |
0.01 |